Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Sarah Laing

Biographic Data

ID7041085
NAMESarah Laing
GIVEN NAMESSarah
FAMILY NAMELaing
SIGNATURELAING S
AFFILIATIONSUniversity of North Carolina at Chapel Hill
ORCID0000-0003-3761-5749
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS1
AUTHOR COUNT2
EDITOR COUNT0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2020
H-INDEX1
  • Impact of substandard and falsified antimalarials in Zambia

    Open Access•Kathryn D Jackson, Colleen R Higgins et al.•ARTICLE•BMC Public Health•2020

    Eliminating substandard and falsified antimalarials is an important step towards a malaria-free Zambia. Beyond the dissemination of insecticide-treated bed nets, indoor residual spraying, and other malaria control measures, attention must also be paid to assure the quality of antimalarial treatments

  • Poor-quality antimalarials further health inequities in Uganda

    Open Access•Daniel R Evans, Colleen R Higgins et al.•ARTICLE•Health Policy and Planning•2019•Cited by: 1•References: 52

    Substandard and falsified medications are a major threat to public health, directly increasing the risk of treatment failure, antimicrobial resistance, morbidity, mortality and health expenditures. While antimalarial medicines are one of the most common to be of poor quality in low- and middle-income countries, their distributional impact has not been examined. This study assessed the health equity impact of substandard and falsified antimalarial…

  • Poor-quality antimalarials further health inequities in Uganda

    Open Access•Daniel R Evans, Colleen R Higgins et al.•ARTICLE•Health Policy and Planning•2019•Cited by: 1•References: 52

    Substandard and falsified medications are a major threat to public health, directly increasing the risk of treatment failure, antimicrobial resistance, morbidity, mortality and health expenditures. While antimalarial medicines are one of the most common to be of poor quality in low- and middle-income countries, their distributional impact has not been examined. This study assessed the health equity impact of substandard and falsified antimalarial…

  • Poor-quality antimalarials further health inequities in Uganda

    Open Access•Daniel R Evans, Colleen R Higgins et al.•ARTICLE•Health Policy and Planning•2019•Cited by: 1•References: 52

    Substandard and falsified medications are a major threat to public health, directly increasing the risk of treatment failure, antimicrobial resistance, morbidity, mortality and health expenditures. While antimalarial medicines are one of the most common to be of poor quality in low- and middle-income countries, their distributional impact has not been examined. This study assessed the health equity impact of substandard and falsified antimalarial…

  • Impact of substandard and falsified antimalarials in Zambia

    Open Access•Kathryn D Jackson, Colleen R Higgins et al.•ARTICLE•BMC Public Health•2020

    Eliminating substandard and falsified antimalarials is an important step towards a malaria-free Zambia. Beyond the dissemination of insecticide-treated bed nets, indoor residual spraying, and other malaria control measures, attention must also be paid to assure the quality of antimalarial treatments

Environmental health (2 works) · Malaria (2 works) · Medicine (2 works) · Pharmaceutical Economics and Policy (2 works) · Pharmaceutical Quality and Counterfeiting (2 works) · Psychological intervention (2 works) · Public health (2 works) · Artemisinin (1 work) · Biostatistics (1 work) · Business (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae